Companies: 10,795·Total market cap: $144.5T
Acacia Diversified Holdings, Inc.

Acacia Diversified Holdings, Inc.

ACCAOTCHealthcare
$0.00
+$0.00(+0.00%)
Market Cap$5428
P/E Ratio
52W High
52W Low

Acacia Diversified Holdings, Inc. (ACCA) PE Ratio — Current & Historical Data

Trailing twelve months (TTM) P/E, forward P/E, PEG, and annual PE history — from market prices and filings.

acca · pe ratio · data through Dec 31, 2019

Core PE Ratio Metrics

Trailing 12 months · TTM

The price-to-earnings (P/E) ratio for Acacia Diversified Holdings, Inc. (ACCA) measures how much investors pay for each dollar of the company's trailing earnings. ACCA's current PE ratio of N/A is calculated by dividing its stock price of $0.00 by its TTM earnings per share of -$0.05.

N/A
P/E Ratio (TTM)N/A — Company is not profitable (TTM)

Source: FMP · /ratios-ttm · /analyst-estimates · 2019-12-31

Forward P/E
N/A
EPS (TTM)
-$0.05
TTM · diluted EPS
PEG Ratio
-0.00
Source: FMP · /ratios-ttm · /ratios annual · /analyst-estimates · /stock-peers · Acacia Diversified Holdings, Inc. SEC 10-K & 10-Q filings · US GAAPUpdated: 2026-06-09

PE Ratio History

1994 – 2019 · Annual
PE Ratio (TTM)
5Y Avg 0.1x
EPS (Annual)

▸ FMP /ratios?period=annual&limit=20 · priceToEarningsRatio + netIncomePerShare (Annual)

Historical PE Range

Past 4 fiscal years · Front-end computed
Average
0.1x
4-yr mean
Median
0.1x
4-yr midpoint
Minimum
0.0x
Lowest year
Maximum
0.3x
Highest year
0.0x
Min
Q1 · 25%0.1x
Median
Q3 · 75%0.3x
Max
Historically Low

At N/A, ACCA's current P/E is lower than in 0% of its annual fiscal year readings over the past 4 years — historically low.

0th percentileHigher than 0 of 4 historical fiscal year readings

Percentile calculated from annual fiscal year data points, not by trading day. Years where PE ≤ 0 or > 9,999 are excluded.

PE Ratio vs Peers

Drug Manufacturers - Specialty & Generic · 6 peers · Annual PE
CompanyMarket CapPE (Annual)vs AvgEPS (TTM)
Acacia Diversified Holdings, Inc.
Acacia Diversified Holdings, Inc.You
ACCA
$0MN/A-$0.05
American Bio Medica Corporation
American Bio Medica Corporation
ABMC
$0MN/A-$0.03
Allied Healthcare Products, Inc.
Allied Healthcare Products, Inc.
AHPIQ
$0MN/A
Gene Biotherapeutics, Inc.
Gene Biotherapeutics, Inc.
CRXM
$0MN/A-$0.02
American CryoStem Corporation
American CryoStem Corporation
CRYO
$0MN/A-$0.05
DermTech, Inc.
DermTech, Inc.
DMTKQ
$0MN/A-$3.09
E-Qure Corp.
E-Qure Corp.
EQUR
$0MN/A-$0.02

* N/A — Company is not profitable (TTM) · excluded from industry average · ▸ FMP /stock-peers + /ratios?limit=1 · priceToEarningsRatio

Annual PE Ratio History

Showing 10 of 20 years
Fiscal Year EndPE RatioEPS (TTM)YoY ChangePE vs Max
2019-12-31Latest
FY2019
$-0.05
2018-12-31
FY2018
$-0.09
2017-12-31
FY2017
$-0.11
2016-12-31
FY2016
$-0.11
2015-12-31
FY2015
$-0.04
2014-12-31
FY2014
$-0.01
2013-12-31
FY2013
$-0.06
2012-12-31
FY2012
$-0.00
2011-12-31
FY2011
$-0.04
2010-12-31
FY2010
$-0.02

▸ FMP /ratios?period=annual&limit=20 · priceToEarningsRatio + netIncomePerShare · Zero extra API

About PE Ratio & Methodology

The price-to-earnings (P/E) ratio for Acacia Diversified Holdings, Inc. (ACCA) measures how much investors pay for each dollar of the company's trailing earnings. ACCA's current PE ratio of N/A is calculated by dividing its stock price of $0.00 by its TTM earnings per share of -$0.05.

PE Ratio = Stock Price ÷ EPS (TTM)
= $0.00 ÷ -$0.05 = N/A
TTMTrailing Twelve Months — sum of the most recent 4 quarterly EPS figures
Forward PEStock price ÷ analyst consensus EPS estimate for the next fiscal year
PEGPE ÷ earnings growth rate — values below 1.0 suggest growth may justify the premium
Figures tie to SEC 10-K/10-Q and FMP ratio endpoints where noted.

Frequently asked questions

ACCA pe ratio · 6 questions

ACCA's current PE ratio is N/A as of 2026-06-09, based on a stock price of $0.00 and TTM EPS of -$0.05. Data sourced from Financial Modeling Prep via ACCA's SEC 10-K and 10-Q filings.

ACCA PE ratioWhat is ACCA PE ratioCurrent PE ratio of ACCAACCA PE ratio today

Source: FMP · /ratios-ttm · /ratios annual · /analyst-estimates · /stock-peers · Acacia Diversified Holdings, Inc. SEC 10-K & 10-Q filings · US GAAP · Updated: 2026-06-09